The TuBerculosis Vaccine Initiative (TBVI) Governance Board would like to announce a vacancy for the Executive Director of the organization. The Board has launched the search for a new Director [...]
TBVI Governance Board Communiqué Tuberculosis (TB) is a major unsolved global health problem. Novel vaccines against TB will be critical tools to ultimately end this silent pandemic. TBVI and its [...]
From 15-18 May 2023, the first annual progress meeting of the MTBVAC phase III clinical trial EDCTP co-funded project took place in Andasibe and Antananarivo, Madagascar. The consortium, composed [...]
The Horizon Europe programme has funded the ITHEMYC project to establish a critical path for selection of promising innovative adjunct TB immunotherapies and progress 2 of these immunotherapies [...]
The Horizon Europe programme has funded the TBVAC-HORIZON project to improve the understanding of lung immunity to tuberculosis infection and to establish a diversified innovative TB vaccine [...]
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: 0031 (0)6 1099 5196
